LSTM Home > LSTM Research > LSTM Online Archive

Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant

Anderson, Enyia, Hughes, Grant ORCID: and Patterson, Ian ORCID: (2021) 'Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant'. Access Microbiology, Vol 3, Issue 4.

acmi000228 GHughes May 21.pdf - Published Version
Available under License Creative Commons Attribution.

Download (527kB) | Preview


Until an effective vaccine against SARS-CoV-2 is available on a widespread scale, the control of the COVID-19 pandemic is
reliant upon effective pandemic control measures. The ability of SARS-CoV-2 to remain viable on surfaces and in aerosols,
means indirect contact transmission can occur and there is an opportunity to reduce transmission using effective disinfectants
in public and communal spaces. Virusend (TX-10), a novel disinfectant, has been developed as a highly effective disinfectant
against a range of microbial agents. Here we investigate the ability of Virusend to inactivate SARS-CoV-2. Using surface and solution inactivation assays, we show that Virusend is able to reduce SARS-CoV-2 viral titre by 4 log10 p.f.u. ml−1 within 1min of contact. Ensuring disinfectants are highly effective against SARS-CoV-2 is important in eliminating environmental sources of the virus to control the COVID-19 pandemic

Item Type: Article
Subjects: QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 250 Anti-infective agents (General)
WA Public Health > WA 105 Epidemiology
WA Public Health > Preventive Medicine > WA 240 Disinfection. Disinfestation. Pesticides (including diseases caused by)
WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections
Faculty: Department: Biological Sciences > Vector Biology Department
Digital Object Identifer (DOI):
Depositing User: Mel Finley
Date Deposited: 13 May 2021 15:24
Last Modified: 13 May 2021 15:24


View details

Actions (login required)

Edit Item Edit Item